BI-4394 - 10mM in DMSO , CAS No.1222173-37-6

CAS: 1222173-37-6 Cat. No.: B654615 Molecular Weight: 446.46 PubChem CID: 45376872
AVAILABLE TO ORDER
GRADE & PURITY 10mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
1ml
B654615-1ml
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$528.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

BI-4394 (MMP13-IN-3) is a potent, selective, and orally active MMP-13 inhibitor ( IC 50 =1 nM ) for the potential treatment of osteoarthritis . BI-4394 is >1000 selective over other MMPs

In Vitro

BI-4394 (Compound 15) is potent in a full-length MMP-13 collagen degradation assay (11 nM) and is able to inhibit degradation of bovine nasal cartilage with an IC 50 of 31 nM. BI-4394 inhibits MMP-2, MMP-9, MMP-10 and MMP-14 with IC 50 s of 18, 8.9, 16 and 8.3 μM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

When dosed orally at 10 mg/kg or i.v. 1 mg/kg, BI-4394 (Compound 15) reaches micromolar plasma levels (AUC=1109±64 nM h/mL), displays modest clearance (CL=34 mL/min/kg), and shows acceptable bioavailability (39%). The V ss is quite low at 0.26 mL/mi/kg rat pharmacokinetic profile. BI-4394 has short terminal elimination half-life (t 1/2 =0.47 h for rat (1 mg/kg, i.v.) and rat (10 mg/kg, orally), respectively) . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Srapgue Dally Rats Dosage: 10 mg/kg (oral gavage); 1 mg/kg (i.v.) Administration: Dosed orally (10 mg/kg); i.v. (1 mg/kg)(Pharmacokinetic Analysis) Result: T 1/2 =0.47 h for rat (1 mg/kg, i.v.) and rat (10 mg/kg, orally) , respectively.

IC50& Target:MMP-13 1 nM (IC 50 ) MMP-14 8.3 μM (IC 50 ) MMP-9 8.9 μM (IC 50 ) MMP-10 16 μM (IC 50 ) MMP-2 18 μM (IC 50 )

Specifications

Specifications & Purity
10mM in DMSO
Biochemical and Physiological Mechanisms
BI-4394 (MMP13-IN-3) is a potent, selective, and orally active MMP-13 inhibitor ( IC 50 =1 nM) for the potential treatment of osteoarthritis. BI-4394 is >1000 selective over other MMPs.
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Names and Identifiers
Isomeric SMILES CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C3=CC(=NN3C)C(=O)NCC4=CC=C(C=C4)C(=O)O
PubChem CID 45376872
Molecular Weight 446.46

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Associated Targets(Human)
MMP13 Tchem Collagenase 3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.